Effect of an individualized bismuth quadruple regimen guided by 10-day or 14-day antibiotic susceptibility testing for first-line eradication treatment of Helicobacter pylori in Ningxia, China
Both 10-day and 14-day AST guided individualized therapy can achieve satisfactory eradication effect. Compared with the 14-day regimen, the 10-day regimen has similar eradication rate and incidence of adverse events and compliance but shorter duration and lower cost.
Authors
- Yanhong Deng (ORCID: https://orcid.org/0000-0001-6873-8026)
- Shengjuan Hu (ORCID: https://orcid.org/0000-0002-6210-576X)
- Yuanyuan Tang (ORCID: https://orcid.org/0000-0003-3956-5685)
- Rui Mu
- Xiaoming Su (ORCID: https://orcid.org/0000-0002-6676-8800)
- Yanling Li (ORCID: https://orcid.org/0009-0006-2328-3666)
- Yuting Wu (ORCID: https://orcid.org/0000-0003-3196-5916)
- Yan Zhou (ORCID: https://orcid.org/0000-0003-3379-2369)
- Qian Hao (ORCID: https://orcid.org/0000-0001-7397-1535)
- Xianmei Chen (ORCID: https://orcid.org/0000-0003-0457-7563)
Institutions
- Ningxia Medical University (CN)
- The Fourth People's Hospital of Ningxia Hui Autonomous Region (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-01-10
- DOI
- https://doi.org/10.3389/fmed.2024.1510376
- Citations
- 1
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Key Research and Development Program of Ningxia